bch logo

Benjamin J. Huang, MD

Pediatric Hematology-Oncology • Medical Oncology
Pediatric Oncology Mission Bay
877-822-4453
Portrait of Benjamin J. Huang
Portrait of Benjamin J. Huang
bch logo

Benjamin J. Huang, MD

Pediatric Hematology-Oncology • Medical Oncology
Pediatric Oncology Mission Bay
877-822-4453

On this page

About me

Dr. Benjamin J. Huang is a hematologist-oncologist who cares for children with leukemia and other cancers.

Huang's research lab aims to develop new strategies for treating leukemia using innovative drug combinations that are informed by biology and genetics. In studying blood cancers, he employs cancer modeling, targeted therapies, functional genomics (how genes affect biological processes) and biomarker identification (finding biological indicators of disease and response, such as the measurement of rare but persistent cancer within the bloodstream and bone marrow). He has a special focus on pediatric acute myeloid leukemia. He works collaboratively with other investigators at UCSF and across North America through the Children's Oncology Group.

Huang earned his medical degree at UCSF, where he also completed a residency in pediatrics and a fellowship in pediatric hematology and oncology.

Education & training

Board certification

  • Pediatric Hematology-Oncology, American Board of Pediatrics/Hematology-Oncology
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Pediatric Hematology-Oncology, UCSF School of Medicine -GME

Residency

  • Pediatrics, UCSF School of Medicine -GME

Degree

  • MD, UCSF School of Medicine

Academic Title

  • Professor-in-Residence

My expertise

Locations

    My research

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.